TrialLeukemia2020

Randomized post-induction and delayed intensification therapy in high-risk pediatric acute lymphoblastic leukemia: long-term results of the international AIEOP-BFM ALL 2000 trial.

Andishe Attarbaschi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.